These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19181472)
21. Assessment of hyperinsulinaemia at the termination of the prolonged fast. Wiesli P; Brändle M; Zapf J; Seiler H; Zwimpfer C; Spinas GA; Schmid C Clin Chim Acta; 2004 Apr; 342(1-2):227-31. PubMed ID: 15026285 [TBL] [Abstract][Full Text] [Related]
22. Cross-validation of commercial enzyme-linked immunosorbent assay and radioimmunoassay for porcine C-peptide concentration measurements in non-human primate serum. Gresch SC; Mutch LA; Janecek JL; Hegstad-Davies RL; Graham ML Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28731212 [TBL] [Abstract][Full Text] [Related]
23. Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes. Van Renterghem P; Van Eenoo P; Geyer H; Schänzer W; Delbeke FT Steroids; 2010 Feb; 75(2):154-63. PubMed ID: 19962394 [TBL] [Abstract][Full Text] [Related]
24. Precision and long-term stability of different estradiol immunoassays assessed in a multi-center quality control study. Reinsberg J; Bätz O; Bertsch T; Bewarder N; Deschner W; Drescher V; Dronsek M; Emami M; Keller R; Klemm M; Koch HU; Meissner J; Plecko T; Schauer I; Schweiger AM; Ullrich A; van de Loo HM; Zwirner M Clin Lab; 2009; 55(5-6):201-6. PubMed ID: 19728553 [TBL] [Abstract][Full Text] [Related]
25. Detection of GH abuse in sport: Past, present and future. Barroso O; Schamasch P; Rabin O Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501 [TBL] [Abstract][Full Text] [Related]
26. Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control. Shahzad K; Kim DH; Kang MJ Clin Biochem; 2007 Nov; 40(16-17):1259-65. PubMed ID: 17884034 [TBL] [Abstract][Full Text] [Related]
27. Measurement of free IGF-I saliva levels: perspectives in the detection of GH/IGF axis in athletes. Antonelli G; Cappellin E; Gatti R; Chiappin S; Spinella P; De Palo EF Clin Biochem; 2007 May; 40(8):545-50. PubMed ID: 17321513 [TBL] [Abstract][Full Text] [Related]
28. Laboratory issues in the implementation of the marker method. Cowan DA; Bartlett C Growth Horm IGF Res; 2009 Aug; 19(4):357-60. PubMed ID: 19574074 [TBL] [Abstract][Full Text] [Related]
30. Statistical issues in implementing the marker method. Bassett EE; Erotokritou-Mulligan I Growth Horm IGF Res; 2009 Aug; 19(4):361-5. PubMed ID: 19515593 [TBL] [Abstract][Full Text] [Related]
31. A third generation approach to detect erythropoietin abuse in athletes. Sharpe K; Ashenden MJ; Schumacher YO Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of commercial ELISA and RIA for measuring porcine C-peptide: implications for research. Graham ML; Gresch SC; Hardy SK; Mutch LA; Janecek JL; Hegstad-Davies RL Xenotransplantation; 2015; 22(1):62-9. PubMed ID: 25291621 [TBL] [Abstract][Full Text] [Related]
33. Validation of an enzyme-linked immunosorbent assay for C-peptide analysis in Cameroon. Asanghanwa M; van Genderen F; Verhaeghen K; Van der Auwera B; Sobngwi E; Mbanya JC; van Schravendijk C Diabetes Res Clin Pract; 2012 Dec; 98(3):459-64. PubMed ID: 23089552 [TBL] [Abstract][Full Text] [Related]
34. Overview of the legal framework applicable to the marker method for the detection of human growth hormone. Young RR; Bielak JS; Horvitz SL Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of commercially available assays for the measurement of equine insulin. Tinworth KD; Wynn PC; Boston RC; Harris PA; Sillence MN; Thevis M; Thomas A; Noble GK Domest Anim Endocrinol; 2011 Aug; 41(2):81-90. PubMed ID: 21741576 [TBL] [Abstract][Full Text] [Related]
36. Analytical validation of commercial immunoassays for the measurement of cardiovascular peptides in the dog. Schellenberg S; Grenacher B; Kaufmann K; Reusch CE; Glaus TM Vet J; 2008 Oct; 178(1):85-90. PubMed ID: 17716935 [TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of an ELISA for quantification of human alpha-1-proteinase inhibitor in complex biological mixtures. Karnaukhova E; Golding B; Ophir Y Biologicals; 2007 Oct; 35(4):285-95. PubMed ID: 17257853 [TBL] [Abstract][Full Text] [Related]
38. Insulin. Thevis M; Thomas A; Schänzer W Handb Exp Pharmacol; 2010; (195):209-26. PubMed ID: 20020367 [TBL] [Abstract][Full Text] [Related]
39. Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay. Agin A; Jeandidier N; Gasser F; Grucker D; Sapin R Diabetes Metab; 2007 Jun; 33(3):205-12. PubMed ID: 17360218 [TBL] [Abstract][Full Text] [Related]